期刊文献+

酯化透明质酸医药学研究进展 被引量:3

Progress of research on esterified hyaluronic acid in medicine
下载PDF
导出
摘要 透明质酸(hyaluronic acid,HA)具有良好的黏弹性和生物相容性,是优良的药物载体,主要用于关节疾病、眼科手术,预防术后粘连,药物传递系统、医疗器械等。由于HA在人体内的吸收和代谢较快,为延长其在体内作用时间,研究人员利用HA分子中多个可修饰位点对其改性,提高其体内稳定性,并进一步引进新的生物活性,得到更广泛用途。目前主要改性方式有交联、酯化、接枝、分子修饰等。本文根据HA酯化产物的用途分类,综述了HA酯化性能改进及应用等方面的研究进展,并展望了其在医药领域的应用前景。 Hyaluronic acid( HA) is a very good drug carrier,which applies in the treatment of arthritis diseases,ophthalmic surgery,prevention of postoperative tissue adhesion,drug delivery system,etc. due to its favourable viscoelasticity and biocompatibility. As HA degraded fast in human body,researchers took use of several active sites in its structure for chemical modifications including crosslinking,esterification,graft and molecular modification,to improve its stability and introduce new bioactivities with more extensive applications. This review describes the development in performance improvement and applications about HA esterification derivatives according to the classification of different use,and prospect its application in the field of medicine.
出处 《中国生化药物杂志》 CAS 北大核心 2014年第9期185-188,共4页 Chinese Journal of Biochemical Pharmaceutics
关键词 透明质酸 酯化 改性 研究进展 hyaluronic acid esterification modified research progress
  • 相关文献

参考文献7

  • 1Maurice N. Collins,Colin Birkinshaw.Hyaluronic acid based scaffolds for tissue engineering—A review[J].Carbohydrate Polymers.2013(2)
  • 2Ki Young Choi,Hyunjin Chung,Kyung Hyun Min,Hong Yeol Yoon,Kwangmeyung Kim,Jae Hyung Park,Ick Chan Kwon,Seo Young Jeong.Self-assembled hyaluronic acid nanoparticles for active tumor targeting[J].Biomaterials.2009(1)
  • 3Eun Ju Oh,Kitae Park,Ki Su Kim,Jiseok Kim,Jeong-A Yang,Ji-Hyun Kong,Min Young Lee,Allan S. Hoffman,Sei Kwang Hahn.Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives[J].Journal of Controlled Release.2009(1)
  • 4C. Radhakumary,A. Maya Nandkumar,Prabha D. Nair.Hyaluronic acid-g-poly(HEMA) copolymer with potential implications for lung tissue engineering[J].Carbohydrate Polymers.2011(2)
  • 5杨翠霞,高锋.透明质酸与其受体CD44在肿瘤研究中的意义[J].肿瘤,2006,26(2):206-209. 被引量:7
  • 6崔媛,段潜,李艳辉.透明质酸的研究进展[J].长春理工大学学报(自然科学版),2011,34(3):101-106. 被引量:45
  • 7孙李平,王晓宇,朱全刚,高申.透明质酸纳米给药载体的研究进展[J].药学服务与研究,2012,12(4):265-269. 被引量:1

二级参考文献36

  • 1郭学平,王春喜,崔大鹏.发酵法制备透明质酸[J].日用化学工业,1994,24(2):47-48. 被引量:14
  • 2Yao Jiong WU,David P. LA PIERRE,Jin WU,Albert J. YEE,Burton B. YANG.The interaction of versican with its binding partners[J].Cell Research,2005,15(7):483-494. 被引量:18
  • 3于学丽,王传栋,李保陆,曹成波.透明质酸的改性及其应用[J].生物医学工程研究,2005,24(1):61-66. 被引量:17
  • 4Lee S J,Ghosh S C, Han H D,et al. Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma [JJ- Clin Cancer Rcs,2012 ,June 12. Epub ahead of print.
  • 5Oyarzun-Ampuero F A, Goycoolea F M, Torres D, et al. A new drug nanocarrier consisting of polyarginine and hyalu- ronic acid[J']. Eur J Pharm Biopharm,2011,79(1) :54-57.
  • 6Cho H J, Yoon I S, Yoon H Y, et al. Polyethylene glycol- conjugated hyaluronie acid-ceramide self-assembled nanoparti-cles for targeted delivery of doxorubicin[J]. Biomaterials, 2012,33(4) :1190-1200.
  • 7Oh E J, Park K, Kim K S, et al. Target specific and long- acting delivery of protein,peptide,and nucleotide therapeutics using hyaluronic acid derivatives[J]. J Control Release,2010, 141(1) :2-12.
  • 8Luo Yi,Ziebell M R,Prestwich G D. A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells[J]. Biomacro- molecules, 2000,1 (2) : 208-218.
  • 9Speranza A,Pellizzaro C, Coradini D. Hyaluronic acid butyric esters in cancer therapy[J]. Anticancer Drugs, 2005,16 (4): 373-379.
  • 10Meo C D,Panza L,Campo F,et al. Novel types of carhorane carrier hyaluronan derivatives via " click chemistry" [J]. Macromol Biosci, 2008,8 (7) : 670-681.

共引文献50

同被引文献25

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部